Literature DB >> 24343972

CIITA: a master regulator of adaptive immunity shows its innate side in the bone.

Mary C Nakamura1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24343972      PMCID： PMC4852740          DOI： 10.1002/jbmr.2161

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN： 0884-0431            Impact factor:   6.741


× No keyword cloud information.
  15 in total

1.  Estrogen deficiency induces bone loss by increasing T cell proliferation and lifespan through IFN-gamma-induced class II transactivator.

Authors:  Simone Cenci; Gianluca Toraldo; M Neale Weitzmann; Cristiana Roggia; Yuhao Gao; Wei Ping Qian; Oscar Sierra; Roberto Pacifici
Journal:  Proc Natl Acad Sci U S A       Date:  2003-08-15       Impact factor: 11.205

Review 2.  Regulation of MHC class II gene expression by the class II transactivator.

Authors:  Walter Reith; Salomé LeibundGut-Landmann; Jean-Marc Waldburger
Journal:  Nat Rev Immunol       Date:  2005-10       Impact factor: 53.106

Review 3.  Regulation of MHC class II expression, a unique regulatory system identified by the study of a primary immunodeficiency disease.

Authors:  M Krawczyk; W Reith
Journal:  Tissue Antigens       Date:  2006-03

4.  Mice lacking the MHC class II transactivator (CIITA) show tissue-specific impairment of MHC class II expression.

Authors:  C H Chang; S Guerder; S C Hong; W van Ewijk; R A Flavell
Journal:  Immunity       Date:  1996-02       Impact factor: 31.745

Review 5.  CATERPILLER: a novel gene family important in immunity, cell death, and diseases.

Authors:  Jenny P-Y Ting; Beckley K Davis
Journal:  Annu Rev Immunol       Date:  2005       Impact factor: 28.527

6.  Early epigenetic events regulate the adaptive immune response gene CIITA.

Authors:  Ninad T Mehta; Agnieszka D Truax; Nathaniel H Boyd; Susanna F Greer
Journal:  Epigenetics       Date:  2011-04       Impact factor: 4.528

7.  Revisiting the specificity of the MHC class II transactivator CIITA in vivo.

Authors:  Luc A Otten; Salomé Leibundgut-Landmann; Joachim Huarte; Isabelle C Kos-Braun; Christine Lavanchy; Emmanuèle Barras; Bettina Borisch; Viktor Steimle; Hans Acha-Orbea; Walter Reith
Journal:  Eur J Immunol       Date:  2006-06       Impact factor: 5.532

8.  Genome-wide expression analyses establish dendritic cells as a new osteoclast precursor able to generate bone-resorbing cells more efficiently than monocytes.

Authors:  A Gallois; J Lachuer; G Yvert; A Wierinckx; F Brunet; C Rabourdin-Combe; C Delprat; P Jurdic; M Mazzorana
Journal:  J Bone Miner Res       Date:  2010-03       Impact factor: 6.741

9.  MHC class II transactivator is an in vivo regulator of osteoclast differentiation and bone homeostasis co-opted from adaptive immunity.

Authors:  Elisa Benasciutti; Elisabetta Mariani; Laura Oliva; Maria Scolari; Egon Perilli; Emmanuele Barras; Enrico Milan; Ugo Orfanelli; Nicola L Fazzalari; Lara Campana; Annalisa Capobianco; Luc Otten; Francesca Particelli; Hans Acha-Orbea; Fabio Baruffaldi; Roberta Faccio; Roberto Sitia; Walter Reith; Simone Cenci
Journal:  J Bone Miner Res       Date:  2014-02       Impact factor: 6.741

Review 10.  Mini-review: Specificity and expression of CIITA, the master regulator of MHC class II genes.

Authors:  Salomé LeibundGut-Landmann; Jean-Marc Waldburger; Michal Krawczyk; Luc A Otten; Tobias Suter; Adriano Fontana; Hans Acha-Orbea; Walter Reith
Journal:  Eur J Immunol       Date:  2004-06       Impact factor: 5.532
View more
  4 in total

1.  Adeno-Associated Virus D-Sequence-Mediated Suppression of Expression of a Human Major Histocompatibility Class II Gene: Implications in the Development of Adeno-Associated Virus Vectors for Modulating Humoral Immune Response.

Authors:  Hyung-Joo Kwon; Keyun Qing; Selvarangan Ponnazhagan; Xu-Shan Wang; David M Markusic; Siddhant Gupte; Shannon E Boye; Arun Srivastava
Journal:  Hum Gene Ther       Date:  2020-04-23       Impact factor: 5.695

2.  Development of potent class II transactivator gene delivery systems capable of inducing de novo MHC II expression in human cells, in vitro and ex vivo.

Authors:  M L Palma; P Duangkhae; B Douradinha; I F T Viana; P O Rigato; R Dhalia; R B Mailliard; S M Barratt-Boyes; E J M Nascimento; T M Oshiro; A J da Silva Duarte; E T A Marques
Journal:  Gene Ther       Date:  2017-04-17       Impact factor: 4.184

3.  SNP-to-gene linking strategies reveal contributions of enhancer-related and candidate master-regulator genes to autoimmune disease.

Authors:  Kushal K Dey; Steven Gazal; Bryce van de Geijn; Samuel Sungil Kim; Joseph Nasser; Jesse M Engreitz; Alkes L Price
Journal:  Cell Genom       Date:  2022-07-13

Review 4.  Role of the major histocompatibility complex class II protein presentation pathway in bone immunity imbalance in postmenopausal osteoporosis.

Authors:  Xiaoning Wang; Xin Zhang; Yidan Han; Xinwei Duan; Jianchang Wang; Hui Yan; Shanshan Wang; Yunteng Xu; Zaishi Zhu; Lili Wang; Yanfeng Huang; Qing Lin; Xue Tan; Junkuan Zhuo; Haifeng Zhang; Min Mao; Weiying Gou; Zhouping Yi; Xihai Li
Journal:  Front Endocrinol (Lausanne)       Date:  2022-08-11       Impact factor: 6.055
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.